Ketan Yerneni, FSM '21

Principal, KdT Ventures

MD by training with a background in translational oncology and neuroscience research. Currently, I am seed-stage biotech investor with significant experience growing platform therapeutics companies. I can help you with pitch preparation, assess your company strategy, understanding the industry landscape, and preparing for a fundraise.